Clinical Trial Update: XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigating XELOX chemotherapy with apatinib as postoperative treatment for locally advanced gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Gastric Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN